Summit Therapeutics Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 16.03 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 12.82B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies. Its lead development candidate is ivonescimab, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis for the treatment of non-small lung cancer (NSCLC) and colorectal cancer (CRC). The company has also combined ivonescimab with chemotherapy, which is in phase III clinical trial for the patients with epidermal growth factor receptor, mutated, and locally advanced or metastatic non-squamous NSCLC; first-line metastatic NSCLC; and first-line unresectable metastatic CRC. It markets its products in the United states, Canada, Europe, Japan, Latin America, Middle East, and Africa. The company was founded in 2003 and is headquartered in Miami, Florida.
Details
| Name | Summit Therapeutics Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 265 |
| Founded | 2003 |
| Ceo | Robert W. Duggan |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US86627T1088 |
| Cusip | 86627T108 |
| Cik | 0001599298 |
| Sic | 2834 |
Key executives
| Name | Title |
|---|---|
| Dr. Mahkam Zanganeh D.D.S., M.B.A. | Co-Chief Executive Officer, President and Director |
| Robert W. Duggan | Co-Chief Executive Officer and Executive Chairman |
| Prof. Kay Elizabeth Davies DBE, FRS CBE | Co-Founder, Chairman of Scientific Advisory Board and Scientific Advisor |
| Bhaskar Anand | Chief Accounting Officer and Head of Finance |
| Nathan LiaBraaten | Senior Director of Investor Relations |
| Dr. Elaine Carla Stracker J.D., Ph.D. | Chief Legal Officer |
| Dave Gancarz CPA | Chief Business and Strategy Officer |
| Dr. Wang Clow Fong ScD | Chief Biometrics Officer |
| Dr. Urte Gayko Ph.D. | Chief Regulatory, Quality and Pharmacovigilance Officer |
| Dr. Allen S. Yang M.D., Ph.D. | Chief Research & Development Strategy Officer |
Contact
| Address | 601 Brickell Key Drive, Suite 1000, Miami, Florida 33131, United States |
| Phone | 305 203 2034 |
| Website | https://www.smmttx.com |